<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="brief-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Cell Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">Cell Rep</journal-id>
<journal-title-group>
<journal-title>Cell Reports</journal-title>
</journal-title-group>
<issn pub-type="epub">2211-1247</issn>
<publisher>
<publisher-name>Cell Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29590610</article-id>
<article-id pub-id-type="pmc">5896230</article-id>
<article-id pub-id-type="publisher-id">S2211-1247(18)30347-4</article-id>
<article-id pub-id-type="doi">10.1016/j.celrep.2018.03.018</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A Transcriptomic Signature of the Hypothalamic Response to Fasting and BDNF Deficiency in Prader-Willi Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Bochukova</surname>
<given-names>Elena G.</given-names>
</name>
<email>e.bochukova@qmul.ac.uk</email>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="corresp" rid="cor1">∗</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lawler</surname>
<given-names>Katherine</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Croizier</surname>
<given-names>Sophie</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff4">4</xref>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Keogh</surname>
<given-names>Julia M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Patel</surname>
<given-names>Nisha</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Strohbehn</surname>
<given-names>Garth</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lo</surname>
<given-names>Kitty K.</given-names>
</name>
<xref ref-type="aff" rid="aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Humphrey</surname>
<given-names>Jack</given-names>
</name>
<xref ref-type="aff" rid="aff6">6</xref>
<xref ref-type="aff" rid="aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hokken-Koelega</surname>
<given-names>Anita</given-names>
</name>
<xref ref-type="aff" rid="aff8">8</xref>
<xref ref-type="aff" rid="aff9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Damen</surname>
<given-names>Layla</given-names>
</name>
<xref ref-type="aff" rid="aff8">8</xref>
<xref ref-type="aff" rid="aff9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Donze</surname>
<given-names>Stephany</given-names>
</name>
<xref ref-type="aff" rid="aff8">8</xref>
<xref ref-type="aff" rid="aff9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bouret</surname>
<given-names>Sebastien G.</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Plagnol</surname>
<given-names>Vincent</given-names>
</name>
<xref ref-type="aff" rid="aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Farooqi</surname>
<given-names>I. Sadaf</given-names>
</name>
<email>isf20@cam.ac.uk</email>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="fn" rid="fn1">10</xref>
<xref ref-type="corresp" rid="cor2">∗∗</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label>University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK</aff>
<aff id="aff2"><label>2</label>The Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK</aff>
<aff id="aff3"><label>3</label>The Saban Research Institute, Developmental Neuroscience Program, and Diabetes and Obesity Program, Children’s Hospital Los Angeles, Center for Endocrinology, Diabetes and Metabolism, University of Southern California, Los Angeles, CA 90027, USA</aff>
<aff id="aff4"><label>4</label>Inserm, Jean-Pierre Aubert Research Center, U1172, University Lille 2, Lille, 59045, France</aff>
<aff id="aff5"><label>5</label>Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland</aff>
<aff id="aff6"><label>6</label>University College London Genetics Institute (UGI), Department of Genetics, Environment and Evolution, University College London, Darwin Building, Gower Street, London, WC1E 6BT, UK</aff>
<aff id="aff7"><label>7</label>Department of Neurodegenerative Disease, University College London Institute of Neurology, London, WC1N 3BG, UK</aff>
<aff id="aff8"><label>8</label>Erasmus University Medical Center, Rotterdam, the Netherlands</aff>
<aff id="aff9"><label>9</label>Dutch Growth Research Foundation, Rotterdam, the Netherlands</aff>
<author-notes>
<corresp id="cor1"><label>∗</label>Corresponding author <email>e.bochukova@qmul.ac.uk</email></corresp>
<corresp id="cor2"><label>∗∗</label>Corresponding author <email>isf20@cam.ac.uk</email></corresp>
<fn id="fn1">
<label>10</label>
<p id="ntpara0010">Lead Contact</p>
</fn>
</author-notes>
<pub-date pub-type="pmc-release">
<day>05</day>
<month>3</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
<pub-date pub-type="collection">
<day>27</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>05</day>
<month>3</month>
<year>2018</year>
</pub-date>
<volume>22</volume>
<issue>13</issue>
<fpage>3401</fpage>
<lpage>3408</lpage>
<history>
<date date-type="received">
<day>7</day>
<month>12</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>7</day>
<month>2</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>5</day>
<month>3</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© 2018 The Author(s)</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p>
</license>
</permissions>
<abstract id="abs0010">
<title>Summary</title>
<p>Transcriptional analysis of brain tissue from people with molecularly defined causes of obesity may highlight disease mechanisms and therapeutic targets. We performed RNA sequencing of hypothalamus from individuals with Prader-Willi syndrome (PWS), a genetic obesity syndrome characterized by severe hyperphagia. We found that upregulated genes overlap with the transcriptome of mouse Agrp neurons that signal hunger, while downregulated genes overlap with the expression profile of Pomc neurons activated by feeding. Downregulated genes are expressed mainly in neuronal cells and contribute to neurogenesis, neurotransmitter release, and synaptic plasticity, while upregulated, predominantly microglial genes are involved in inflammatory responses. This transcriptional signature may be mediated by reduced brain-derived neurotrophic factor expression. Additionally, we implicate disruption of alternative splicing as a potential molecular mechanism underlying neuronal dysfunction in PWS. Transcriptomic analysis of the human hypothalamus may identify neural mechanisms involved in energy homeostasis and potential therapeutic targets for weight loss.</p>
</abstract>
<abstract abstract-type="graphical" id="abs0015">
<title>Graphical Abstract</title>
<fig id="undfig1" position="anchor">
<graphic xlink:href="fx1"></graphic>
</fig>
</abstract>
<abstract abstract-type="author-highlights" id="abs0020">
<title>Highlights</title>
<p>
<list id="ulist0010" list-type="simple">
<list-item id="u0010">
<label>•</label>
<p id="p0010">Overlap between genes expressed in human PWS hypothalamus and mouse Agrp neurons</p>
</list-item>
<list-item id="u0015">
<label>•</label>
<p id="p0015">Downregulated genes are involved in neuronal development</p>
</list-item>
<list-item id="u0020">
<label>•</label>
<p id="p0020">SNORD116 deletion reduces neural development and survival in cells</p>
</list-item>
<list-item id="u0025">
<label>•</label>
<p id="p0025">Alternative splicing is disturbed in PWS</p>
</list-item>
</list>
</p>
</abstract>
<abstract abstract-type="teaser" id="abs0025">
<p>Prader-Willi syndrome (PWS) is a genetic obesity syndrome. Bochukova et al. report gene expression changes in the hypothalamus of people with PWS that support neurodegeneration and neuroinflammation as key processes involved in this condition.</p>
</abstract>
<kwd-group id="kwrds0010">
<title>Keywords</title>
<kwd>hypothalamus</kwd>
<kwd>Prader-Willi syndrome</kwd>
<kwd>BDNF</kwd>
<kwd>Agrp</kwd>
<kwd>obesity</kwd>
<kwd>SNORD116</kwd>
</kwd-group>
</article-meta>
<notes>
<p id="misc0010">Published: March 27, 2018</p>
</notes>
</front>
<body>
<sec id="sec1">
<title>Introduction</title>
<p id="p0030">Neural circuits within the hypothalamus regulate energy balance in response to peripheral nutrient-related cues (<xref ref-type="bibr" rid="bib1">Andermann and Lowell, 2017</xref>, <xref ref-type="bibr" rid="bib18">Gautron et al., 2015</xref>). Leptin-responsive Agouti-related protein (Agrp)-expressing neurons in the arcuate nucleus of the hypothalamus are activated during fasting or caloric deficit to drive an increase in food intake, while in the nutritionally replete or fed state, Pro-opiomelanocortin (Pomc) neurons are activated to reduce food intake (<xref ref-type="bibr" rid="bib13">Cowley et al., 1999</xref>, <xref ref-type="bibr" rid="bib14">Cowley et al., 2001</xref>). In humans, loss-of-function mutations that disrupt the function of these neural circuits result in severe obesity, demonstrating their pivotal role in human energy homeostasis (<xref ref-type="bibr" rid="bib29">O’Rahilly and Farooqi, 2008</xref>, <xref ref-type="bibr" rid="bib40">van der Klaauw and Farooqi, 2015</xref>).</p>
<p id="p0035">However, experiments in rodents (<xref ref-type="bibr" rid="bib3">Atasoy et al., 2012</xref>, <xref ref-type="bibr" rid="bib6">Betley et al., 2013</xref>) and genetic studies in humans (<xref ref-type="bibr" rid="bib22">Hendricks et al., 2017</xref>) suggest that the neural mechanisms that regulate energy homeostasis are complex and that many molecular components of these circuits remain to be discovered (<xref ref-type="bibr" rid="bib36">Sternson et al., 2016</xref>). One potential approach to identifying genes and pathways is to use transcriptomic analysis of key tissues and organs to identify changes in gene expression in response to a perturbation or genetic manipulation. The specificity of these approaches has been enhanced by recent technological developments that have enabled the labeling, sorting, and RNA sequencing of molecularly defined populations of neurons in the mouse brain. To this end, the recent detailed analysis of high-quality gene expression data from mouse Agrp and Pomc neurons has provided a framework for investigating the genes whose expression changes with fasting and feeding (<xref ref-type="bibr" rid="bib11">Campbell et al., 2017</xref>, <xref ref-type="bibr" rid="bib23">Henry et al., 2015</xref>). Although comparable studies of specific cell types are not feasible in humans, transcriptional analysis of hypothalamic tissue from people with molecularly defined subtypes of severe obesity has the potential to inform the discovery of neural mechanisms involved in energy balance. Here, we characterized the hypothalamic transcriptome of individuals with Prader-Willi syndrome (PWS), a genetic obesity syndrome caused by loss of expression of paternally expressed genes and noncoding RNAs on chromosome 15q11–q13 (<xref ref-type="bibr" rid="bib12">Cassidy et al., 2012</xref>).</p>
</sec>
<sec id="sec2">
<title>Results and Discussion</title>
<p id="p0040">RNA sequencing was performed on post-mortem hypothalamic tissue from four PWS patients and four age-matched controls from the University of Maryland Brain and Tissue Bank (<xref ref-type="supplementary-material" rid="mmc1">Figure S1</xref>). Although samples from controls matched for both age and obesity were not available, the body mass index (BMI) values of patients and controls were comparable (<xref ref-type="supplementary-material" rid="mmc1">Figure S1</xref>A). Principal-component analysis revealed segregation between PWS and control samples (<xref ref-type="fig" rid="fig1">Figure 1</xref>A). We identified 3,676 differentially expressed genes (DEGs) in PWS individuals compared with controls (<xref ref-type="supplementary-material" rid="mmc2">Table S1</xref>; Benjamini-Hochberg false discovery rate [FDR] &lt; 0.25; 658 with FDR &lt; 0.05). The most highly downregulated genes (FDR &lt; 5 × 10<sup>−5</sup>) were located in the PWS critical region (<xref ref-type="fig" rid="fig1">Figure 1</xref>B). A random subset of genes were validated by qRT-PCR (<xref ref-type="supplementary-material" rid="mmc1">Figure S1</xref>E). In the absence of high-quality hypothalamic tissue for replication, we compared our data with a previous high-density microarray study of hypothalamic gene expression in two PWS patients (<xref ref-type="bibr" rid="bib17">Falaleeva et al., 2015</xref>) and found significant overlap of dysregulated genes (<xref ref-type="fig" rid="fig1">Figures 1</xref>C and <xref ref-type="supplementary-material" rid="mmc1">S1</xref>D; <xref ref-type="supplementary-material" rid="mmc2">Table S1</xref>). However, there was minimal overlap with datasets derived from PWS induced pluripotent stem cell (iPSC)-derived neuronal cell lines (data not shown); notably, we did not find reduced expression of the obesity-associated gene PCSK1 reported recently (<xref ref-type="bibr" rid="bib10">Burnett et al., 2017b</xref>).<fig id="fig1"><label>Figure 1</label><caption><p>Genome-wide Transcriptional Changes in PWS Hypothalamus</p><p>(A) Principal-component (PC) analysis showing segregation of PWS and control hypothalamic samples.</p><p>(B) Heatmap representing the top 45 most significantly DEGs shown as within-gene <italic>Z</italic> score (left) and rlog-normalized read counts (right).</p><p>(C) Venn diagrams illustrating differentially down- and upregulated genes in PWS versus control samples in this study (discovery set) and overlap with genes from a previous study in PWS (replication set) (<xref ref-type="bibr" rid="bib17">Falaleeva et al., 2015</xref>).</p><p>(D) Heatmaps representing the expression of brain cell-type-specific genes among the DEGs displayed as within-gene <italic>Z</italic> score of rlog-normalized read counts.</p><p>See also <xref ref-type="supplementary-material" rid="mmc1">Figure S1</xref> and <xref ref-type="supplementary-material" rid="mmc2">Table S1</xref>.</p></caption><graphic xlink:href="gr1"></graphic></fig></p>
<p id="p0045">To identify the cellular origin of DEGs, we ranked genes on the basis of their relative expression in single-cell transcriptomic data from neurons, astrocytes, microglia, oligodendrocytes, and endothelial cells (<xref ref-type="supplementary-material" rid="mmc1">Supplemental Experimental Procedures</xref>). We found that downregulated genes were enriched for neuronal markers (p = 3 × 10<sup>−8</sup>), while upregulated genes were enriched for microglial genes (p = 9 × 10<sup>−5</sup>) (<xref ref-type="fig" rid="fig1">Figure 1</xref>D). Further analysis using CIBERSORT (<xref ref-type="bibr" rid="bib28">Newman et al., 2015</xref>) also showed that PWS hypothalamic tissue was characterized by a reduction in neurons (<xref ref-type="supplementary-material" rid="mmc1">Figure S1</xref>F). Interestingly, this cellular transcriptomic profile aligns with that seen in autism (<xref ref-type="bibr" rid="bib30">Parikshak et al., 2016</xref>), in several neurodegenerative diseases, and in the aging brain (<xref ref-type="bibr" rid="bib7">Blalock et al., 2004</xref>, <xref ref-type="bibr" rid="bib26">Lu et al., 2004</xref>) (<xref ref-type="supplementary-material" rid="mmc1">Figure S2</xref>A), suggesting that fundamental mechanisms regulating neuronal maintenance may contribute to a range of human neurological diseases, including PWS.</p>
<sec id="sec2.1">
<title>Overlap of the Human PWS Transcriptome with the Transcriptome of Agrp Neurons in Fasting</title>
<p id="p0050">To identify potential candidate obesity genes, we compared PWS DEGs with genes expressed in hypothalamic Agrp and Pomc neurons in mice (<xref ref-type="bibr" rid="bib11">Campbell et al., 2017</xref>, <xref ref-type="bibr" rid="bib23">Henry et al., 2015</xref>) (<xref ref-type="supplementary-material" rid="mmc1">Supplemental Experimental Procedures</xref>). We found that expression of Agrp was increased 3-fold in PWS hypothalamus versus controls (p = 0.01), suggesting this potent orexigenic may play a role in the hyperphagia associated with PWS. Other upregulated genes were predominantly expressed in mouse Agrp neurons that signal hunger, while genes downregulated in PWS were relatively overrepresented in mouse Pomc neurons that signal the fed state (Fisher’s exact test, odds ratio [OR] = 7.2, p = 2.3 × 10<sup>−4</sup>) (<xref ref-type="fig" rid="fig2">Figures 2</xref>A and <xref ref-type="supplementary-material" rid="mmc1">S2</xref>). A significant number of PWS upregulated genes were expressed in mouse Agrp neurons and upregulated in fasted animals (Fisher’s exact test, OR = 5.3, p = 10<sup>−12</sup>; <xref ref-type="fig" rid="fig2">Figure 2</xref>B), suggesting that these genes represent a conserved signature of the neural response to fasting or food deprivation.<fig id="fig2"><label>Figure 2</label><caption><p>Dysregulated Gene Co-expression Modules in PWS Hypothalamus Converge with Fasting and Feeding Responses in Specific Hypothalamic Cell Types from Mice</p><p>(A) Venn diagrams illustrating the number of DEGs that are down- and upregulated in PWS hypothalami compared with controls and their expression in Pomc, Agrp, and other neurons (<xref ref-type="bibr" rid="bib11">Campbell et al., 2017</xref>, <xref ref-type="bibr" rid="bib23">Henry et al., 2015</xref>). For comparison, the reference gene sets (Pomc, 261 genes; Agrp, 167 genes; other neurons, 1,589 genes) are included in <xref ref-type="supplementary-material" rid="mmc1">Figure S2</xref>A.</p><p>(B) Number of PWS DEGs (up- or downregulated) that are expressed in Agrp neurons in the fasted versus fed state (q &lt; 0.05 in <xref ref-type="bibr" rid="bib23">Henry et al., 2015</xref>).</p><p>(C) Gene co-expression modules among upregulated PWS DEGs. Hierarchical clustering of DEGs upregulated in PWS with log<sub>2</sub> fold change &gt;1.5. The heatmap illustrates pairwise gene-gene correlation clustering (Pearson correlation, distance = 1-cor, Ward clustering). The sidebar (right) displays the overlap with genes previously reported upregulated (red) or downregulated (green) in Agrp neurons in the fasted versus fed state (q &lt; 0.05 in <xref ref-type="bibr" rid="bib23">Henry et al., 2015</xref>).</p><p>See also <xref ref-type="supplementary-material" rid="mmc1">Figure S2</xref> and <xref ref-type="supplementary-material" rid="mmc2">Table S1</xref>.</p></caption><graphic xlink:href="gr2"></graphic></fig></p>
<p id="p0055">Using hierarchical cluster analyses of high-confidence DEGs (absolute log fold change &gt; 1.5), we identified sets of co-expressed genes and gene modules whose expression was upregulated in Agrp neurons in the fasted state (<xref ref-type="fig" rid="fig2">Figure 2</xref>C). We observed increased expression of ribosomal proteins involved in protein synthesis. This finding aligns with the upregulation of genes involved in endoplasmic reticulum (ER) protein translocation and Golgi trafficking seen in Agrp neurons in mice with fasting (<xref ref-type="bibr" rid="bib23">Henry et al., 2015</xref>) and may reflect increased production of neuropeptides for secretion. Several genes downregulated in PWS, and also in mouse Pomc neurons, were involved in synaptic transmission and neuronal maintenance and integrity. As loss-of-function mutations in some of these genes (SRPX2 and ZBTB16; <xref ref-type="supplementary-material" rid="mmc2">Table S1</xref>) are known to cause human neurological disorders, their reduced expression could contribute to both the obesity and the neurodevelopmental phenotype of PWS.</p>
<p id="p0060">A subset of co-regulated genes dysregulated in the PWS hypothalamus are expressed in Agrp neurons in fasting and are known to play a role in energy homeostasis and adipocyte biology in rodents (SOCS3, ANGPTL4, FOSL1, FOSL2, and STC2; <xref ref-type="supplementary-material" rid="mmc2">Table S1</xref>). Interestingly, bone morphogenic factor-3 (BMP3), whose expression is markedly decreased in mouse Agrp neurons in the fasted state (−17.7-fold, q = 2.0 × 10<sup>−5</sup>; <xref ref-type="bibr" rid="bib23">Henry et al., 2015</xref>), was found to be significantly decreased in the human PWS hypothalamus. These findings generate hypotheses that will need to be explored further. Characterization of the neurons in which these genes are expressed and the processes they regulate, as well as DEGs expressed in other transcriptionally distinct neuronal cell types, may provide insights into the mechanisms involved in human energy balance.</p>
</sec>
<sec id="sec2.2">
<title>Human PWS Hypothalamus Is Characterized by Downregulation of Genes Involved in Neuronal Function and Upregulation of Microglial Genes and Inflammatory Markers</title>
<p id="p0065">We found that downregulated DEGs were significantly enriched for genes involved in certain processes, namely, neurogenesis, neurotransmitter release, and synaptic function (<xref ref-type="fig" rid="fig3">Figure 3</xref>A). Using Ingenuity Pathway Analysis, we identified 11 potential regulators of clusters of downregulated DEGs (<xref ref-type="supplementary-material" rid="mmc3">Table S2</xref>), including the neurotrophin brain-derived neurotrophic factor (BDNF) and its receptor, TrkB (encoded by NTRK2). Putative BDNF/TrkB targets among the downregulated DEGs were predominantly related to synaptic processes (<xref ref-type="fig" rid="fig3">Figure 3</xref>B). This finding is intriguing, as BDNF is a major regulator of the development, maturation, and maintenance of neurons and a modulator of synaptic plasticity (<xref ref-type="bibr" rid="bib35">Snider, 1994</xref>). Moreover, in mice and humans, genetic disruption of BDNF and TrkB causes developmental delay, stereotyped behaviors, impaired pain sensation, hyperphagia, and severe obesity (<xref ref-type="bibr" rid="bib19">Gray et al., 2006</xref>, <xref ref-type="bibr" rid="bib41">Yeo et al., 2004</xref>), phenotypes that show some overlap with those seen in PWS. We also obtained several post-mortem brain samples for histology. Very few samples were of sufficient quality, limiting quantitative analysis, but fluorescence <italic>in situ</italic> hybridization of human hypothalamic tissue suggested that the number of cells expressing BDNF and NTRK2 mRNA was reduced in the ventromedial nucleus of the hypothalamus in PWS (<xref ref-type="fig" rid="fig3">Figures 3</xref>C and <xref ref-type="supplementary-material" rid="mmc1">S3</xref>). We measured levels of plasma BDNF (potentially derived from platelets) in patients with PWS versus age-matched obese controls, but we did not find a significant difference (<xref ref-type="supplementary-material" rid="mmc1">Figure S3</xref>G), in contrast to one previous study (<xref ref-type="bibr" rid="bib21">Han et al., 2010</xref>). Possible explanations are that BDNF levels are known to vary considerably in plasma versus serum and among assays; additionally, plasma BDNF may not reflect BDNF expression in the brain.<fig id="fig3"><label>Figure 3</label><caption><p>Pathways Predicted to Be Affected by Changes in Gene Expression Seen in PWS Hypothalamus</p><p>(A) A gene annotation network illustrating terms (Gene Ontology, Reactome, Key) enriched among downregulated DEGs. Nodes represent downregulated DEGs annotated with illustrated terms; edges join pairs of genes annotated with the respective term.</p><p>(B) Ingenuity Pathway Analysis (IPA) regulator effects analysis indicates the inhibition of regulatory factors NTRK2, ADCYAP1, and BDNF (top) with predicted effects on target genes and processes. Phenotypes predicted to occur as a consequence of the gene expression changes are shown in blue (inhibited) or orange (enhanced).</p><p>(C) Representative FISH images of BDNF and NTRK2 mRNA-expressing cells in the ventromedial nucleus of the hypothalamus and oxytocin mRNA-expressing cells in the paraventricular nucleus of the hypothalamus in PWS and control samples (BDNF [n = 2 PWS, n = 2 controls], NTRK2 [n = 2 PWS, n = 1 control], and oxytocin [n = 2 PWS, n = 1 control]).</p><p>(D) A gene annotation network illustrating terms enriched among upregulated DEGs. Nodes and edges as in <xref ref-type="fig" rid="fig2">Figure 2</xref>A.</p><p>(E) IPA upstream regulator analysis indicates inhibition of TNF/NFKb signaling.</p><p>(F) Representative immunohistochemistry images of S100Beta- and GFAP-immunoreactive cells in the ventromedial nucleus of the hypothalamus in PWS and control samples.</p><p>See also <xref ref-type="supplementary-material" rid="mmc1">Figure S3</xref> and <xref ref-type="supplementary-material" rid="mmc3">Table S2</xref>.</p></caption><graphic xlink:href="gr3"></graphic></fig></p>
<p id="p0070">A previous histopathological study of the PWS hypothalamus found a significantly reduced number of oxytocin neurons (<xref ref-type="bibr" rid="bib37">Swaab et al., 1995</xref>), and clinical trials of intranasal oxytocin administration in PWS are ongoing (<xref ref-type="bibr" rid="bib38">Tauber et al., 2017</xref>). In our study, we found a low level of oxytocin mRNA and a smaller number of cells immunoreactive for oxytocin in the paraventricular nucleus in PWS samples (<xref ref-type="fig" rid="fig3">Figure 3</xref>C), supporting the key role of oxytocin as well as BDNF in the neuropathology of PWS. Additional studies are needed to replicate these findings and to investigate the potential loss of other neuronal populations (including Pomc and Agrp neurons) within the hypothalamus in PWS.</p>
<p id="p0075">We found that upregulated genes in the PWS hypothalamus were enriched for cytokine signaling and inflammatory processes (<xref ref-type="fig" rid="fig3">Figure 3</xref>D; <xref ref-type="supplementary-material" rid="mmc3">Table S2</xref>). The most statistically significant predicted regulator of these genes was tumor necrosis factor (TNF)-alpha, which plays a critical role in systemic inflammation (<xref ref-type="fig" rid="fig3">Figure 3</xref>E; <xref ref-type="supplementary-material" rid="mmc3">Table S2</xref>). In the human hypothalamus, we studied expression of S100b (a glial-specific protein marker of neural damage) and GFAP (an astrocyte filament protein that plays a critical role in synaptic function and is reduced in neurodegenerative disorders but increased in brain injury). We found that S100b protein levels were increased and GFAP immunoreactivity was decreased in the PWS hypothalamus compared with controls (<xref ref-type="fig" rid="fig3">Figure 3</xref>F). These findings overlap with data from other neurodevelopmental conditions (<xref ref-type="bibr" rid="bib20">Griffin et al., 1989</xref>). Further studies with larger sample sizes are needed to explore the potential relevance of these findings.</p>
</sec>
<sec id="sec2.3">
<title>Targeted Deletion of SNORD116 Affects Neuronal Differentiation, Proliferation, and Survival</title>
<p id="p0080">Chromosomal deletions that cause PWS vary in size and thus can affect a number of genes and noncoding RNAs. None of the mouse models involving deletion of the homologous region fully recapitulate the human PWS phenotype (<xref ref-type="bibr" rid="bib32">Resnick et al., 2013</xref>); as such, investigation of the molecular mechanisms that underlie the clinical phenotype has been challenging. The minimal genetic lesion associated with severe hyperphagia and obesity in PWS contains a cluster of noncoding small nucleolar RNAs (snoRNAs) referred to as the SNORD116 gene cluster (<xref ref-type="bibr" rid="bib15">de Smith et al., 2009</xref>, <xref ref-type="bibr" rid="bib34">Sahoo et al., 2008</xref>). Postnatal deletion of SNORD116 in the mediobasal hypothalamus has recently been shown to lead to increased food intake in mice (<xref ref-type="bibr" rid="bib31">Polex-Wolf et al., 2018</xref>). To test whether loss of SNORD116 affects neuronal development and maintenance, as suggested by our transcriptomics analysis and in line with a rodent model (<xref ref-type="bibr" rid="bib9">Burnett et al., 2017a</xref>), we deleted a 57.4 kb genomic segment encompassing the SNORD116 cluster using CRISPR-Cas9 in a SH-SY5Y neuroblastoma human cell line (<xref ref-type="supplementary-material" rid="mmc1">Figure S4</xref>A). We found that SNORD116-deficient cells exhibited reduced neuronal differentiation, cell proliferation, and survival compared with wild-type cells (<xref ref-type="fig" rid="fig4">Figures 4</xref>A–4C). A higher proportion of SNORD116-deficient cells displayed neurites when treated with BDNF (mean 13%) compared with no treatment (mean 23%, p = 0.005, two-tailed t test), whereas no significant difference was observed within wild-type cells (28% with no treatment, 36% with BDNF; p = 0.2, two-tailed t test). Cumulatively, these data identify a transcriptomic signature in PWS consistent with marked hypothalamic neurodegeneration, which may be mediated in part by reduced expression of the neurotrophin BDNF and its receptor, TrkB. These data align with experiments in cortical neurons of the SNORD116 knockout mouse (<xref ref-type="bibr" rid="bib9">Burnett et al., 2017a</xref>). Neuronal loss is associated with a marked inflammatory response in the hypothalamus, which may be a primary defect, secondary to the neurodegenerative process or, as microglia have a role in synaptic development and function (<xref ref-type="bibr" rid="bib4">Barres, 2008</xref>), an inflammatory response to disordered synaptic plasticity in the PWS hypothalamus.<fig id="fig4"><label>Figure 4</label><caption><p>Deletion of SNORD116 Impairs Neuronal Differentiation, Proliferation, and Survival</p><p>(A) Targeted deletion of SNORD116 (SNORD116del) affects the neuronal differentiation of SH-SY5Y cells, cultured for 7 days in retinoic acid (RA) in the absence (n = 5) or presence (n = 3) of BDNF. Left: representative images of wild-type (WT) and SNORD116del cells; right: quantification plot.</p><p>(B) Cellular proliferation measured by EdU incorporation at day 7 (n = 3).</p><p>(C) Cell survival measured by FACS at day 7 in culture (n = 6).</p><p>(D) Overlap between <italic>in silico</italic> predicted SNORD116 gene targets and PWS differentially expressed and differentially spliced genes.</p><p>All data are presented as mean ± SEM. Statistical significance was measured using two-tailed Student’s t test (<sup>∗</sup>p &lt; 0.05, <sup>∗∗</sup>p &lt; 0.01, <sup>∗∗∗</sup>p &lt; 0.001; ns, non-significance). See also <xref ref-type="supplementary-material" rid="mmc1">Figure S4</xref> and <xref ref-type="supplementary-material" rid="mmc4">Tables S3</xref> and <xref ref-type="supplementary-material" rid="mmc5">S4</xref>.</p></caption><graphic xlink:href="gr4"></graphic></fig></p>
</sec>
<sec id="sec2.4">
<title>Predicted snoRNA Targets and Detection of Reduced Splicing Efficiency</title>
<p id="p0085">SNORD116 and the closely related SNORD115 cluster belong to a group of orphan snoRNAs with presumed non-canonical functions. SNORD115 has been shown to regulate the post-transcriptional processing of a single pre-mRNA, the serotonin 2c receptor, through alternative splicing and RNA editing (<xref ref-type="bibr" rid="bib25">Kishore and Stamm, 2006</xref>). Using snoTARGET, we identified 588 predicted targets for snoRNAs within protein-coding genes (<xref ref-type="fig" rid="fig4">Figure 4</xref>D; <xref ref-type="supplementary-material" rid="mmc4">Table S3</xref>), some of which were differentially expressed in PWS hypothalamus (<xref ref-type="supplementary-material" rid="mmc1">Figure S4</xref>B). Further studies will be needed to test the functional significance of these findings. Interestingly, RNA-specific adenosine deaminase (ADARB1), a predicted target that is significantly downregulated (<xref ref-type="supplementary-material" rid="mmc1">Figure S4</xref>B), is involved in pre-mRNA editing of glutamate receptor subunit B and when deleted causes hyperphagia and obesity in mice (<xref ref-type="bibr" rid="bib39">Terajima et al., 2017</xref>).</p>
<p id="p0090">As snoRNAs can modulate RNA splicing (<xref ref-type="bibr" rid="bib42">Yin et al., 2012</xref>), a process that plays a major role in human neuronal development, we performed a transcriptome-wide search for evidence of alternative splicing (<xref ref-type="supplementary-material" rid="mmc1">Supplemental Experimental Procedures</xref>). We found evidence of differential use of alternative splice variants in PWS samples compared with controls (<xref ref-type="supplementary-material" rid="mmc5">Table S4</xref>). Focusing on 180 loci with evidence of differential use of two alternative splice variants, the most frequently observed type of splice variant in PWS was retained introns (<xref ref-type="supplementary-material" rid="mmc5">Table S4</xref>; <xref ref-type="supplementary-material" rid="mmc1">Figure S4</xref>). Of note, we did not find evidence for differential splicing of the serotonin 2c receptor (<xref ref-type="supplementary-material" rid="mmc1">Figure S4</xref>C). Genes with putative differential splicing did not tend to be differentially expressed, consistent with decoupling of differential expression and splicing as seen in other disorders; exceptions included genes involved in microglial and inflammatory processes, which were among the top-ranked alternatively spliced genes (<xref ref-type="supplementary-material" rid="mmc5">Table S4</xref>). Motif searches within retained introns and 250 bp flanking regions indicated the presence of binding sites for canonical serine/arginine-rich splicing factors, and the presence of binding sites with predicted similarity to FUS splicing factor binding motifs (<xref ref-type="supplementary-material" rid="mmc1">Figure S4</xref>E). The FUS splicing factor regulates alternative splicing in the brain and has been previously linked to neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) (<xref ref-type="bibr" rid="bib24">Ishigaki et al., 2012</xref>, <xref ref-type="bibr" rid="bib33">Rogelj et al., 2012</xref>).</p>
<p id="p0095">In summary, in this study of the human hypothalamus in a small number of individuals with PWS, we identified a transcriptomic signature characterized by neuronal loss, altered neuro-plasticity, and neuroinflammation. Of note, several neuroimaging studies and case reports in PWS have identified structural abnormalities that would be consistent with a reduced number of neurons, such as reduced gray matter volume in a number of cortical areas and abnormal gyrification (<xref ref-type="bibr" rid="bib27">Manning and Holland, 2015</xref>). We identify a potential role for BDNF in PWS that requires further exploration and may have therapeutic relevance for this complex neuro-behavioral disorder. Additionally, we demonstrate that transcriptomic analysis of the human hypothalamus can generate testable hypotheses of potential relevance to the understanding of the neural circuits involved in human energy homeostasis.</p>
</sec>
</sec>
<sec id="sec3">
<title>Experimental Procedures</title>
<sec id="sec3.1">
<title>Human Samples</title>
<p id="p0100">Hypothalamic specimens used in the study were obtained at autopsy from control subjects with no reported clinical signs and patients with genetic diagnoses of PWS through the University of Maryland Brain Bank at the University of Maryland (<xref ref-type="supplementary-material" rid="mmc1">Figure S1</xref>A). All procedures were approved by the University of Cambridge Human Biology Research Ethics Committee (HBREC.2014.14).</p>
</sec>
<sec id="sec3.2">
<title>RNA Sequencing and Analysis</title>
<p id="p0105">Total RNA was prepared by tissue homogenization in Trizol reagent (Thermo Fisher Scientific) of about one-third of hypothalamus. Sequencing of RNA samples was performed by the University College London (UCL) Genomics core facility, using the TruSeq poly-A mRNA method (Illumina) and a HiSeq 2000 machine (Illumina). Differential expression, splicing, and pathway analysis are described in detail in <xref ref-type="supplementary-material" rid="mmc1">Supplemental Experimental Procedures</xref>, as is the validation of DEGs using qRT-PCR.</p>
</sec>
<sec id="sec3.3">
<title><italic>In Silico</italic> Prediction of SNORD116 Gene Targets</title>
<p id="p0110">Genome-wide <italic>in silico</italic> prediction of SNORD116 targets was performed using snoTARGET software (<xref ref-type="bibr" rid="bib5">Bazeley et al., 2008</xref>) and RNA-cofold from the Vienna RNA package (<ext-link ext-link-type="uri" id="intref0010" xlink:href="http://www.tbi.univie.ac.at/RNA/">http://www.tbi.univie.ac.at/RNA/</ext-link>).</p>
</sec>
<sec id="sec3.4">
<title>Cross-Species Comparison with Agrp and Pomc Neuronal Subtypes and Response to Food Deprivation</title>
<p id="p0115">Reference gene sets for broad neuronal subtype classifications were derived from <xref ref-type="bibr" rid="bib11">Campbell et al. (2017)</xref> as described in <xref ref-type="supplementary-material" rid="mmc1">Supplemental Experimental Procedures</xref>. Reference gene sets for fasting response in Agrp neurons were obtained from <xref ref-type="bibr" rid="bib23">Henry et al. (2015)</xref> using a threshold of q &lt; 0.05 (unless otherwise stated) to define differential expression between fasting conditions.</p>
</sec>
<sec id="sec3.5">
<title>Immunohistochemistry and Fluorescence <italic>In Situ</italic> Hybridization</title>
<p id="p0120">Immunohistochemistry was performed as reported previously (<xref ref-type="bibr" rid="bib8">Bouret et al., 2004</xref>) using the following primary antibodies: guinea pig anti-oxytocin (Peninsula Laboratories), rabbit anti-GFAP (Dako), and rabbit anti-s100beta (Abcam). Secondary antibodies were Alexa Fluor 488 donkey anti-guinea-pig IgGs or Alexa Fluor 488 goat anti-rabbit IgGs (Thermo Fisher Scientific). For the fluorescence <italic>in situ</italic> hybridization (FISH) experiments, sense and antisense digoxigenin-labeled riboprobes were generated from plasmids containing PCR fragments of BDNF and NTRK2 (generously provided by Dr. Baoji Xu, The Scripps Research Institute). Staining density and cell number were calculated using ImageJ analysis software (NIH). Full details are presented in <xref ref-type="supplementary-material" rid="mmc1">Supplemental Experimental Procedures</xref>.</p>
</sec>
<sec id="sec3.6">
<title>Cellular Studies</title>
<p id="p0125">SH-SY5Y (ATCC CRL-2266) cells were used in all the cellular assays. We used a well-established protocol to differentiate SH-SY5Y cells into neurons with retinoic acid (<xref ref-type="bibr" rid="bib16">Encinas et al., 2000</xref>). Full details on maintenance, neuronal differentiation, proliferation, and cell survival are presented in <xref ref-type="supplementary-material" rid="mmc1">Supplemental Experimental Procedures</xref>.</p>
</sec>
<sec id="sec3.7">
<title>SNORD116 Cluster Deletion Using CRISPR-Cas9</title>
<p id="p0130">We applied a cloning-free CRISPR protocol using gBlocks (gene fragments) encoding FE-modified single guide RNAs (sgRNAs) promoting enhanced stability (<xref ref-type="bibr" rid="bib2">Arbab et al., 2015</xref>). Two gBlocks carrying the guide flanking the SNORD116 cluster on chr15q11.2 were nucleofected alongside GFP-expressing Cas9 plasmid PX458into the SH-SY5Y line. Fluorescence-activated cell sorting (FACS)-sorted cells were screened for successful editing using conventional PCR and confirmed by Sanger sequencing. Full details are presented in <xref ref-type="supplementary-material" rid="mmc1">Supplemental Experimental Procedures</xref>.</p>
</sec>
<sec id="sec3.8">
<title>Statistical Analysis</title>
<p id="p0135">Statistical analyses were performed using GraphPad Prism version 6.0 for MacOS X. Data are represented as mean ± SEM. A two-tailed Student’s unpaired t test was used, and p values &lt; 0.05 were considered to indicate statistical significance.</p>
</sec>
</sec>
<sec id="sec4">
<title>Data and Software Availability</title>
<p id="p0140">The accession number for the RNA sequencing data reported in this paper is EGA: EGAS00001002901.</p>
</sec>
</body>
<back>
<ref-list id="cebib0010">
<title>References</title>
<ref id="bib1">
<element-citation id="sref1" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andermann</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Lowell</surname>
<given-names>B.B.</given-names>
</name>
</person-group>
<article-title>Toward a wiring diagram understanding of appetite control</article-title>
<source/>Neuron
          <volume>95</volume>
<year>2017</year>
<fpage>757</fpage>
<lpage>778</lpage>
<pub-id pub-id-type="pmid">28817798</pub-id>
</element-citation>
</ref>
<ref id="bib2">
<element-citation id="sref2" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arbab</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Srinivasan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hashimoto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Geijsen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sherwood</surname>
<given-names>R.I.</given-names>
</name>
</person-group>
<article-title>Cloning-free CRISPR</article-title>
<source/>Stem Cell Reports
          <volume>5</volume>
<year>2015</year>
<fpage>908</fpage>
<lpage>917</lpage>
<pub-id pub-id-type="pmid">26527385</pub-id>
</element-citation>
</ref>
<ref id="bib3">
<element-citation id="sref3" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atasoy</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Betley</surname>
<given-names>J.N.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>H.H.</given-names>
</name>
<name>
<surname>Sternson</surname>
<given-names>S.M.</given-names>
</name>
</person-group>
<article-title>Deconstruction of a neural circuit for hunger</article-title>
<source/>Nature
          <volume>488</volume>
<year>2012</year>
<fpage>172</fpage>
<lpage>177</lpage>
<pub-id pub-id-type="pmid">22801496</pub-id>
</element-citation>
</ref>
<ref id="bib4">
<element-citation id="sref4" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barres</surname>
<given-names>B.A.</given-names>
</name>
</person-group>
<article-title>The mystery and magic of glia: a perspective on their roles in health and disease</article-title>
<source/>Neuron
          <volume>60</volume>
<year>2008</year>
<fpage>430</fpage>
<lpage>440</lpage>
<pub-id pub-id-type="pmid">18995817</pub-id>
</element-citation>
</ref>
<ref id="bib5">
<element-citation id="sref5" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bazeley</surname>
<given-names>P.S.</given-names>
</name>
<name>
<surname>Shepelev</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Talebizadeh</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Fedorova</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Filatov</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Fedorov</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>snoTARGET shows that human orphan snoRNA targets locate close to alternative splice junctions</article-title>
<source/>Gene
          <volume>408</volume>
<year>2008</year>
<fpage>172</fpage>
<lpage>179</lpage>
<pub-id pub-id-type="pmid">18160232</pub-id>
</element-citation>
</ref>
<ref id="bib6">
<element-citation id="sref6" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Betley</surname>
<given-names>J.N.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Z.F.</given-names>
</name>
<name>
<surname>Ritola</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Sternson</surname>
<given-names>S.M.</given-names>
</name>
</person-group>
<article-title>Parallel, redundant circuit organization for homeostatic control of feeding behavior</article-title>
<source/>Cell
          <volume>155</volume>
<year>2013</year>
<fpage>1337</fpage>
<lpage>1350</lpage>
<pub-id pub-id-type="pmid">24315102</pub-id>
</element-citation>
</ref>
<ref id="bib7">
<element-citation id="sref7" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blalock</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Geddes</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>K.C.</given-names>
</name>
<name>
<surname>Porter</surname>
<given-names>N.M.</given-names>
</name>
<name>
<surname>Markesbery</surname>
<given-names>W.R.</given-names>
</name>
<name>
<surname>Landfield</surname>
<given-names>P.W.</given-names>
</name>
</person-group>
<article-title>Incipient Alzheimer’s disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses</article-title>
<source/>Proc. Natl. Acad. Sci. U S A
          <volume>101</volume>
<year>2004</year>
<fpage>2173</fpage>
<lpage>2178</lpage>
<pub-id pub-id-type="pmid">14769913</pub-id>
</element-citation>
</ref>
<ref id="bib8">
<element-citation id="sref8" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bouret</surname>
<given-names>S.G.</given-names>
</name>
<name>
<surname>Draper</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Simerly</surname>
<given-names>R.B.</given-names>
</name>
</person-group>
<article-title>Trophic action of leptin on hypothalamic neurons that regulate feeding</article-title>
<source/>Science
          <volume>304</volume>
<year>2004</year>
<fpage>108</fpage>
<lpage>110</lpage>
<pub-id pub-id-type="pmid">15064420</pub-id>
</element-citation>
</ref>
<ref id="bib9">
<element-citation id="sref9" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burnett</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Hubner</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>LeDuc</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Morabito</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Carli</surname>
<given-names>J.F.M.</given-names>
</name>
<name>
<surname>Leibel</surname>
<given-names>R.L.</given-names>
</name>
</person-group>
<article-title>Loss of the imprinted, non-coding Snord116 gene cluster in the interval deleted in the Prader Willi syndrome results in murine neuronal and endocrine pancreatic developmental phenotypes</article-title>
<source/>Hum. Mol. Genet.
          <volume>26</volume>
<year>2017</year>
<fpage>4606</fpage>
<lpage>4616</lpage>
<pub-id pub-id-type="pmid">28973544</pub-id>
</element-citation>
</ref>
<ref id="bib10">
<element-citation id="sref10" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burnett</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>LeDuc</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Sulsona</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Paull</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Rausch</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Eddiry</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Carli</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Morabito</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Skowronski</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Hubner</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome</article-title>
<source/>J. Clin. Invest.
          <volume>127</volume>
<year>2017</year>
<fpage>293</fpage>
<lpage>305</lpage>
<pub-id pub-id-type="pmid">27941249</pub-id>
</element-citation>
</ref>
<ref id="bib11">
<element-citation id="sref11" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Campbell</surname>
<given-names>J.N.</given-names>
</name>
<name>
<surname>Macosko</surname>
<given-names>E.Z.</given-names>
</name>
<name>
<surname>Fenselau</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Pers</surname>
<given-names>T.H.</given-names>
</name>
<name>
<surname>Lyubetskaya</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tenen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Goldman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Verstegen</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Resch</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>McCarroll</surname>
<given-names>S.A.</given-names>
</name>
</person-group>
<article-title>A molecular census of arcuate hypothalamus and median eminence cell types</article-title>
<source/>Nat. Neurosci.
          <volume>20</volume>
<year>2017</year>
<fpage>484</fpage>
<lpage>496</lpage>
<pub-id pub-id-type="pmid">28166221</pub-id>
</element-citation>
</ref>
<ref id="bib12">
<element-citation id="sref12" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cassidy</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Driscoll</surname>
<given-names>D.J.</given-names>
</name>
</person-group>
<article-title>Prader-Willi syndrome</article-title>
<source/>Genet. Med.
          <volume>14</volume>
<year>2012</year>
<fpage>10</fpage>
<lpage>26</lpage>
<pub-id pub-id-type="pmid">22237428</pub-id>
</element-citation>
</ref>
<ref id="bib13">
<element-citation id="sref13" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cowley</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Pronchuk</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Dinulescu</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Colmers</surname>
<given-names>W.F.</given-names>
</name>
<name>
<surname>Cone</surname>
<given-names>R.D.</given-names>
</name>
</person-group>
<article-title>Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat</article-title>
<source/>Neuron
          <volume>24</volume>
<year>1999</year>
<fpage>155</fpage>
<lpage>163</lpage>
<pub-id pub-id-type="pmid">10677034</pub-id>
</element-citation>
</ref>
<ref id="bib14">
<element-citation id="sref14" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cowley</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Smart</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Rubinstein</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cerdán</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Diano</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Horvath</surname>
<given-names>T.L.</given-names>
</name>
<name>
<surname>Cone</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Low</surname>
<given-names>M.J.</given-names>
</name>
</person-group>
<article-title>Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus</article-title>
<source/>Nature
          <volume>411</volume>
<year>2001</year>
<fpage>480</fpage>
<lpage>484</lpage>
<pub-id pub-id-type="pmid">11373681</pub-id>
</element-citation>
</ref>
<ref id="bib15">
<element-citation id="sref15" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Smith</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Purmann</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Walters</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Holder</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Van Haelst</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Brady</surname>
<given-names>A.F.</given-names>
</name>
<name>
<surname>Fairbrother</surname>
<given-names>U.L.</given-names>
</name>
<name>
<surname>Dattani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Keogh</surname>
<given-names>J.M.</given-names>
</name>
</person-group>
<article-title>A deletion of the HBII-85 class of small nucleolar RNAs (snoRNAs) is associated with hyperphagia, obesity and hypogonadism</article-title>
<source/>Hum. Mol. Genet.
          <volume>18</volume>
<year>2009</year>
<fpage>3257</fpage>
<lpage>3265</lpage>
<pub-id pub-id-type="pmid">19498035</pub-id>
</element-citation>
</ref>
<ref id="bib16">
<element-citation id="sref16" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Encinas</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Iglesias</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Muhaisen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ceña</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Gallego</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Comella</surname>
<given-names>J.X.</given-names>
</name>
</person-group>
<article-title>Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells</article-title>
<source/>J. Neurochem.
          <volume>75</volume>
<year>2000</year>
<fpage>991</fpage>
<lpage>1003</lpage>
<pub-id pub-id-type="pmid">10936180</pub-id>
</element-citation>
</ref>
<ref id="bib17">
<element-citation id="sref17" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Falaleeva</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Surface</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>de la Grange</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Stamm</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>SNORD116 and SNORD115 change expression of multiple genes and modify each other’s activity</article-title>
<source/>Gene
          <volume>572</volume>
<year>2015</year>
<fpage>266</fpage>
<lpage>273</lpage>
<pub-id pub-id-type="pmid">26220404</pub-id>
</element-citation>
</ref>
<ref id="bib18">
<element-citation id="sref18" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gautron</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Elmquist</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>K.W.</given-names>
</name>
</person-group>
<article-title>Neural control of energy balance: translating circuits to therapies</article-title>
<source/>Cell
          <volume>161</volume>
<year>2015</year>
<fpage>133</fpage>
<lpage>145</lpage>
<pub-id pub-id-type="pmid">25815991</pub-id>
</element-citation>
</ref>
<ref id="bib19">
<element-citation id="sref19" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gray</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yeo</surname>
<given-names>G.S.</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Morton</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Adlam</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Keogh</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Yanovski</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>El Gharbawy</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Tung</surname>
<given-names>Y.C.</given-names>
</name>
</person-group>
<article-title>Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene</article-title>
<source/>Diabetes
          <volume>55</volume>
<year>2006</year>
<fpage>3366</fpage>
<lpage>3371</lpage>
<pub-id pub-id-type="pmid">17130481</pub-id>
</element-citation>
</ref>
<ref id="bib20">
<element-citation id="sref20" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Griffin</surname>
<given-names>W.S.</given-names>
</name>
<name>
<surname>Stanley</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>MacLeod</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Perrot</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>C.L.</given-names>
<suffix>3rd</suffix>
</name>
<name>
<surname>Araoz</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease</article-title>
<source/>Proc. Natl. Acad. Sci. U S A
          <volume>86</volume>
<year>1989</year>
<fpage>7611</fpage>
<lpage>7615</lpage>
<pub-id pub-id-type="pmid">2529544</pub-id>
</element-citation>
</ref>
<ref id="bib21">
<element-citation id="sref21" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Muehlbauer</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>H.N.</given-names>
</name>
<name>
<surname>Newgard</surname>
<given-names>C.B.</given-names>
</name>
<name>
<surname>Haqq</surname>
<given-names>A.M.</given-names>
</name>
</person-group>
<article-title>Lower brain-derived neurotrophic factor in patients with prader-willi syndrome compared to obese and lean control subjects</article-title>
<source/>J. Clin. Endocrinol. Metab.
          <volume>95</volume>
<year>2010</year>
<fpage>3532</fpage>
<lpage>3536</lpage>
<pub-id pub-id-type="pmid">20427492</pub-id>
</element-citation>
</ref>
<ref id="bib22">
<element-citation id="sref22" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hendricks</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Bochukova</surname>
<given-names>E.G.</given-names>
</name>
<name>
<surname>Marenne</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Keogh</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Atanassova</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bounds</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wheeler</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mistry</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Henning</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Körner</surname>
<given-names>A.</given-names>
</name>
<collab>Understanding Society Scientific Group</collab>
<collab>EPIC-CVD Consortium</collab>
<collab>UK10K Consortium</collab>
</person-group>
<article-title>Rare variant analysis of human and rodent obesity genes in individuals with severe childhood obesity</article-title>
<source/>Sci. Rep.
          <volume>7</volume>
<year>2017</year>
<fpage>4394</fpage>
<pub-id pub-id-type="pmid">28663568</pub-id>
</element-citation>
</ref>
<ref id="bib23">
<element-citation id="sref23" publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Henry</surname>
<given-names>F.E.</given-names>
</name>
<name>
<surname>Sugino</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tozer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Branco</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sternson</surname>
<given-names>S.M.</given-names>
</name>
</person-group>
<chapter-title>Cell Type-Specific Transcriptomics of Hypothalamic Energy-Sensing Neuron Responses to Weight-Loss</chapter-title>
<year>2015</year>
<publisher-name>Elife</publisher-name>
<publisher-loc>Cambridge</publisher-loc>
<fpage>4</fpage>
</element-citation>
</ref>
<ref id="bib24">
<element-citation id="sref24" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishigaki</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Masuda</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fujioka</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Iguchi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Katsuno</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shibata</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Urano</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Sobue</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ohno</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Position-dependent FUS-RNA interactions regulate alternative splicing events and transcriptions</article-title>
<source/>Sci. Rep.
          <volume>2</volume>
<year>2012</year>
<fpage>529</fpage>
<pub-id pub-id-type="pmid">22829983</pub-id>
</element-citation>
</ref>
<ref id="bib25">
<element-citation id="sref25" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kishore</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Stamm</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C</article-title>
<source/>Science
          <volume>311</volume>
<year>2006</year>
<fpage>230</fpage>
<lpage>232</lpage>
<pub-id pub-id-type="pmid">16357227</pub-id>
</element-citation>
</ref>
<ref id="bib26">
<element-citation id="sref26" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kao</surname>
<given-names>S.Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kohane</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yankner</surname>
<given-names>B.A.</given-names>
</name>
</person-group>
<article-title>Gene regulation and DNA damage in the ageing human brain</article-title>
<source/>Nature
          <volume>429</volume>
<year>2004</year>
<fpage>883</fpage>
<lpage>891</lpage>
<pub-id pub-id-type="pmid">15190254</pub-id>
</element-citation>
</ref>
<ref id="bib27">
<element-citation id="sref27" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manning</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Holland</surname>
<given-names>A.J.</given-names>
</name>
</person-group>
<article-title>Puzzle pieces: neural structure and function in Prader-Willi syndrome</article-title>
<source/>Diseases
          <volume>3</volume>
<year>2015</year>
<fpage>382</fpage>
<lpage>415</lpage>
<pub-id pub-id-type="pmid">28943631</pub-id>
</element-citation>
</ref>
<ref id="bib28">
<element-citation id="sref28" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Newman</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Gentles</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hoang</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Diehn</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Alizadeh</surname>
<given-names>A.A.</given-names>
</name>
</person-group>
<article-title>Robust enumeration of cell subsets from tissue expression profiles</article-title>
<source/>Nat. Methods
          <volume>12</volume>
<year>2015</year>
<fpage>453</fpage>
<lpage>457</lpage>
<pub-id pub-id-type="pmid">25822800</pub-id>
</element-citation>
</ref>
<ref id="bib29">
<element-citation id="sref29" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Rahilly</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Farooqi</surname>
<given-names>I.S.</given-names>
</name>
</person-group>
<article-title>Human obesity as a heritable disorder of the central control of energy balance</article-title>
<source/>Int. J. Obes.
          <volume>32</volume>
<issue>Suppl 7</issue>
<year>2008</year>
<fpage>S55</fpage>
<lpage>S61</lpage>
</element-citation>
</ref>
<ref id="bib30">
<element-citation id="sref30" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parikshak</surname>
<given-names>N.N.</given-names>
</name>
<name>
<surname>Swarup</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Belgard</surname>
<given-names>T.G.</given-names>
</name>
<name>
<surname>Irimia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ramaswami</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gandal</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Hartl</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Leppa</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Ubieta</surname>
<given-names>L.T.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism</article-title>
<source/>Nature
          <volume>540</volume>
<year>2016</year>
<fpage>423</fpage>
<lpage>427</lpage>
<pub-id pub-id-type="pmid">27919067</pub-id>
</element-citation>
</ref>
<ref id="bib31">
<element-citation id="sref31" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Polex-Wolf</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>B.Y.</given-names>
</name>
<name>
<surname>Larder</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tadross</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rimmington</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bosch</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Cenzano</surname>
<given-names>V.J.</given-names>
</name>
<name>
<surname>Ayuso</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Rainbow</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Hypothalamic loss of Snord116 recapitulates the hyperphagia of Prader-Willi syndrome</article-title>
<source/>J. Clin. Invest.
          <volume>128</volume>
<year>2018</year>
<fpage>960</fpage>
<lpage>969</lpage>
<pub-id pub-id-type="pmid">29376887</pub-id>
</element-citation>
</ref>
<ref id="bib32">
<element-citation id="sref32" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Resnick</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Nicholls</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Wevrick</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Recommendations for the investigation of animal models of Prader-Willi syndrome</article-title>
<source/>Mamm. Genome
          <volume>24</volume>
<year>2013</year>
<fpage>165</fpage>
<lpage>178</lpage>
<pub-id pub-id-type="pmid">23609791</pub-id>
</element-citation>
</ref>
<ref id="bib33">
<element-citation id="sref33" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rogelj</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Easton</surname>
<given-names>L.E.</given-names>
</name>
<name>
<surname>Bogu</surname>
<given-names>G.K.</given-names>
</name>
<name>
<surname>Stanton</surname>
<given-names>L.W.</given-names>
</name>
<name>
<surname>Rot</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Curk</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zupan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sugimoto</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Modic</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Haberman</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain</article-title>
<source/>Sci. Rep.
          <volume>2</volume>
<year>2012</year>
<fpage>603</fpage>
<pub-id pub-id-type="pmid">22934129</pub-id>
</element-citation>
</ref>
<ref id="bib34">
<element-citation id="sref34" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sahoo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>del Gaudio</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>German</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Shinawi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>S.U.</given-names>
</name>
<name>
<surname>Person</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Garnica</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>Beaudet</surname>
<given-names>A.L.</given-names>
</name>
</person-group>
<article-title>Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster</article-title>
<source/>Nat. Genet.
          <volume>40</volume>
<year>2008</year>
<fpage>719</fpage>
<lpage>721</lpage>
<pub-id pub-id-type="pmid">18500341</pub-id>
</element-citation>
</ref>
<ref id="bib35">
<element-citation id="sref35" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Snider</surname>
<given-names>W.D.</given-names>
</name>
</person-group>
<article-title>Functions of the neurotrophins during nervous system development: what the knockouts are teaching us</article-title>
<source/>Cell
          <volume>77</volume>
<year>1994</year>
<fpage>627</fpage>
<lpage>638</lpage>
<pub-id pub-id-type="pmid">8205613</pub-id>
</element-citation>
</ref>
<ref id="bib36">
<element-citation id="sref36" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sternson</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Atasoy</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Betley</surname>
<given-names>J.N.</given-names>
</name>
<name>
<surname>Henry</surname>
<given-names>F.E.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>An emerging technology framework for the neurobiology of appetite</article-title>
<source/>Cell Metab.
          <volume>23</volume>
<year>2016</year>
<fpage>234</fpage>
<lpage>253</lpage>
<pub-id pub-id-type="pmid">26724860</pub-id>
</element-citation>
</ref>
<ref id="bib37">
<element-citation id="sref37" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swaab</surname>
<given-names>D.F.</given-names>
</name>
<name>
<surname>Purba</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Hofman</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases</article-title>
<source/>J. Clin. Endocrinol. Metab.
          <volume>80</volume>
<year>1995</year>
<fpage>573</fpage>
<lpage>579</lpage>
<pub-id pub-id-type="pmid">7852523</pub-id>
</element-citation>
</ref>
<ref id="bib38">
<element-citation id="sref38" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tauber</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Boulanouar</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Diene</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Çabal-Berthoumieu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ehlinger</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Fichaux-Bourin</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Molinas</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Faye</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Valette</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pourrinet</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>The use of oxytocin to improve feeding and social skills in infants with Prader-Willi syndrome</article-title>
<source/>Pediatrics
          <volume>139</volume>
<year>2017</year>
<fpage>e20162976</fpage>
<pub-id pub-id-type="pmid">28100688</pub-id>
</element-citation>
</ref>
<ref id="bib39">
<element-citation id="sref39" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Terajima</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yoshitane</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ozaki</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shimba</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kuroda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Iwasaki</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Fukada</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>ADARB1 catalyzes circadian A-to-I editing and regulates RNA rhythm</article-title>
<source/>Nat. Genet.
          <volume>49</volume>
<year>2017</year>
<fpage>146</fpage>
<lpage>151</lpage>
<pub-id pub-id-type="pmid">27893733</pub-id>
</element-citation>
</ref>
<ref id="bib40">
<element-citation id="sref40" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Klaauw</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Farooqi</surname>
<given-names>I.S.</given-names>
</name>
</person-group>
<article-title>The hunger genes: pathways to obesity</article-title>
<source/>Cell
          <volume>161</volume>
<year>2015</year>
<fpage>119</fpage>
<lpage>132</lpage>
<pub-id pub-id-type="pmid">25815990</pub-id>
</element-citation>
</ref>
<ref id="bib41">
<element-citation id="sref41" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yeo</surname>
<given-names>G.S.</given-names>
</name>
<name>
<surname>Connie Hung</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Rochford</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Keogh</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sivaramakrishnan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>O’Rahilly</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Farooqi</surname>
<given-names>I.S.</given-names>
</name>
</person-group>
<article-title>A de novo mutation affecting human TrkB associated with severe obesity and developmental delay</article-title>
<source/>Nat. Neurosci.
          <volume>7</volume>
<year>2004</year>
<fpage>1187</fpage>
<lpage>1189</lpage>
<pub-id pub-id-type="pmid">15494731</pub-id>
</element-citation>
</ref>
<ref id="bib42">
<element-citation id="sref42" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yin</surname>
<given-names>Q.F.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.W.</given-names>
</name>
<name>
<surname>Carmichael</surname>
<given-names>G.G.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.L.</given-names>
</name>
</person-group>
<article-title>Long noncoding RNAs with snoRNA ends</article-title>
<source/>Mol. Cell
          <volume>48</volume>
<year>2012</year>
<fpage>219</fpage>
<lpage>230</lpage>
<pub-id pub-id-type="pmid">22959273</pub-id>
</element-citation>
</ref>
</ref-list>
<sec id="app2" sec-type="supplementary-material">
<title>Supplemental Information</title>
<p id="p0165">
<supplementary-material content-type="local-data" id="mmc1">
<caption>
<title>Document S1. Supplemental Experimental Procedures and Figures S1–S4</title>
</caption>
<media xlink:href="mmc1.pdf"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="mmc2">
<caption>
<title>Table S1. DEGs in PWS Patients versus Controls Displayed by Ensembl GeneID, Related to Figures 1 and 2</title>
<p>Grey shading indicates genes located in the PWS region. Column “ncRNA” indicates gene names for Ensembl gene biotypes lincRNA, miRNA, processed transcript, TEC (‘to be experimentally confirmed’); or overlapping miRNAs. Also shown are overlaps with Falaleeva et al. (2015) and putative function of genes among co-expressed gene clusters overlapping with Henry et al. (2015) fasted versus fed in Agrp neurons.</p>
</caption>
<media xlink:href="mmc2.xlsx"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="mmc3">
<caption>
<title>Table S2. IPA Upstream Regulator Analysis of Down, Up, or All DEGs, Related to Figure 3</title>
<p>IPA Ingenuity Upstream Regulator Analysis reporting putative upstream regulators top-ranked by “Activation z-score,” and p values (Fisher’s Exact Test) for overlaps with putative target genes (see Supplemental Experimental Procedures).</p>
</caption>
<media xlink:href="mmc3.xlsx"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="mmc4">
<caption>
<title>Table S3. List of Potential SNORD116 Targets Generated Using Software snoTARGET (Bazeley et al., 2008), Related to Figure 4</title>
</caption>
<media xlink:href="mmc4.xlsx"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="mmc5">
<caption>
<title>Table S4. Differential Splicing in PWS versus Controls, Related to Figures 4 and S4</title>
<p>List of differential splicing events displayed thresholded to FDR &lt; 0.25.</p>
</caption>
<media xlink:href="mmc5.xlsx"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="mmc6">
<caption>
<title>Document S2. Article plus Supplemental Information</title>
</caption>
<media xlink:href="mmc6.pdf"></media>
</supplementary-material>
</p>
</sec>
<ack id="ack0010">
<title>Acknowledgments</title>
<p>The authors would like to thank the donors, their families, and the staff of the University of Maryland Brain Bank and the PWS patients and parents from the Dutch PWS cohort studies. Human tissue was obtained from University of Maryland Brain and Tissue Bank, which is a Brain and Tissue Repository of the NIH NeuroBioBank. We thank the core facility at UCL, the Cambridge National Institute of Health Research (NIHR) Biomedical Research Centre (BRC) core laboratory, and the Children’s Hospital Los Angeles (CHLA) histology core. We also thank Professor Mark Lalande (University of Connecticut) for sharing the RNA-seq data from iPSC-derived neuronal cell lines. This work was supported by the <funding-source id="gs1">Wellcome Trust</funding-source> (098497/Z/12/Z), the <funding-source id="gs2">NIHR Cambridge Biomedical Research Centre</funding-source>, and the <funding-source id="gs3">Bernard Wolfe Health Neuroscience Endowment</funding-source> (all to I.S.F.), the <funding-source id="gs4">NIH</funding-source> (grants DK84142 and DK102780 to S.G.B.), the <funding-source id="gs5">Foundation for Prader-Willi Research</funding-source> (to S.G.B.), a <funding-source id="gs6">Society for Endocrinology</funding-source> early career grant (to E.G.B.), and a <funding-source id="gs7">Royal Society</funding-source> research grant (RG160311 to E.G.B.). J.H. is funded by a <funding-source id="gs8">Medical Research Council (MRC)</funding-source> studentship grant number (516700).</p>
<sec id="sec5">
<title>Author Contributions</title>
<p id="p0150">E.G.B. and I.S.F. conceived and directed the study. E.G.B., K.L., K.K.L., J.H., and V.P. carried out the RNA sequencing and all downstream analysis. S.C. and S.G.B. performed the <italic>in situ</italic> hybridization and immunohistochemical experiments and analyses. N.P. and E.G.B. performed the functional experiments on SNORD116. G.S. and E.G.B. performed the <italic>in silico</italic> SNORD116 work. J.M.K., I.S.F., A.H.-K., L.D., and S.D. recruited patients and controls and contributed to the analysis of human samples. All authors analyzed and interpreted the results. E.G.B., K.L., and I.S.F. wrote the manuscript with contributions from all authors.</p>
</sec>
<sec id="sec7">
<title>Declaration of Interests</title>
<p id="p0155">The authors declare no competing interests.</p>
</sec>
</ack>
<fn-group>
<fn fn-type="supplementary-material" id="app1">
<p id="p0160">Supplemental Information includes Supplemental Experimental Procedures, four figures, and four tables and can be found with this article online at <ext-link ext-link-type="doi" id="intref0015" xlink:href="10.1016/j.celrep.2018.03.018">https://doi.org/10.1016/j.celrep.2018.03.018</ext-link>.</p>
</fn>
</fn-group>
</back>
</article>
</pmc-articleset>